Objective To evaluate the serum histamine-releasing activity of patients with primary acquired cold urticaria (PACU).
目的探讨原发性获得性寒冷性荨麻疹的组胺释放活性。
Conclusion: the results suggest that mizolastine may be effective and safe in the treatment of primary acquired cold urticaria.
结论：咪唑斯汀治疗原发性获得性寒冷性荨麻疹安全、有效。
Conclusion: the results suggest that mizolastine may be effective and safe in the treatment of primary acquired cold urticaria.
结论：咪唑斯汀治疗原发性获得性寒冷性荨麻疹安全、有效。
应用推荐